A landmark study led by researchers at the Malaria Atlas Project (MAP), recently published in The Lancet, provides the most comprehensive and current global maps of p.falciparum and p.vivax malaria from 2000 to 2022, offering vital clues in the global battle to eradicate malaria. MAP’s newest paper includes global high-resolution maps of malaria prevalence, incidence and mortality, which are crucial for tracking localised progress against the disease and informing strategic malaria control efforts.

Malaria remains a leading cause of illness and death globally, with countries in sub–Saharan Africa (SSA) bearing a disproportionate burden. Global high–resolution maps of malaria prevalence, incidence, and mortality are crucial for tracking spatially heterogeneous progress against the disease and to inform strategic malaria control efforts. We present the latest such maps, the first since 2019, which cover years 2000–2022. The maps are accompanied by administrative level summaries and include estimated COVID–19 pandemic–related impacts on malaria burden.

Using advanced spatial and temporal modelling, the study estimates changes in malaria prevalence, incidence, and mortality across 133 countries. It highlights major reductions in disease burden over the past two decades, particularly in high-transmission regions, and identifies areas where progress has stalled or reversed. These insights are essential for tracking progress, targeting interventions, and supporting countries working toward malaria elimination.

Explore the full dataset, visualisations, and interactive maps through our open-access platform:

🌍 Malaria Data Explorer – Global Maps 2000–2022
📖 Read the full publication